Abstract
The Relationship between Transplant Status and Patient-Reported Outcomes in Patients with FLT3-Mutated Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results from the Phase 3 Admiral Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have